Q1 earnings are due to be out on Monday, April 28. As of writing, that’s less than 24 hours away. Analysts expect a modest ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Bristol-Myers Squibb is trading near all-time high dividend and free cash flow yields. Learn why BMY stock is a Buy.

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter 2025 results on April 29, 2025. The ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here ...

On the heels of a clinical setback for Bristol Myers Squibb’s schizophrenia newcomer Cobenfy, the New Jersey pharma is ...

A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers ...

Shares of Acurx Pharmaceuticals, Inc. (ACXP) have been struggling lately and have lost 15.9% over the past week. However, a hammer chart pattern was formed in ... close forms a long lower wick (or ...

These five safety net portfolio stocks pay a 5% or higher dividend and have consistently raised their payouts over many ...

NASHVILLE, TN, UNITED STATES, April 21, 2025 / EINPresswire.com / -- U.S. Department of Health and Human Services Secretary ...